Whole Health Pharmaceuticals, Inc. is committed to maintaining transparency and fostering trust with our investors. Our Investor Relations section provides comprehensive information on our financial performance, corporate governance, and strategic initiatives. We strive to keep our investors informed and engaged, ensuring they have access to the latest updates and reports.

 

Financial Reports

 

Our financial reports provide detailed insights into our financial performance, including balance sheets, income statements, cash flow statements, and key financial ratios. These reports are essential for investors to understand the financial health and operational efficiency of Whole Health Pharmaceuticals, Inc.

​

• Quarterly Financial Reports: Detailed quarterly reports that provide a snapshot of our financial performance, including revenue, expenses, and profit margins.

• Annual Financial Reports: Comprehensive annual reports that offer a thorough analysis of our financial performance over the fiscal year, including audited financial statements and management’s discussion and analysis.

 

• Earnings Releases: Regular updates on our earnings performance, including key financial metrics and highlights from the reporting period.

ANNUAL REPORT

Our annual reports offer a comprehensive overview of our business operations, strategic initiatives, and financial performance. These reports provide valuable insights into our progress, challenges, and future plans.

• Annual Report 2023: Download PDF
• Annual Report 2022: Download PDF
• Annual Report 2021:  Download PDF

 

REPORT CONTENT

​

• Chairman’s Message: Insights from our Chairman on the WHP's strategic direction and key achievements.

• CEO’s Letter: An overview from our CEO on the company’s performance, market conditions, and future outlook.

• Business Review: A detailed review of our business operations, including key developments, product launches, and market expansion.

• Financial Statements: Audited financial statements, including balance sheets, income statements, and cash flow statements.

• Sustainability and CSR: Updates on our sustainability initiatives and corporate social responsibility (CSR) activities.

 

CORPORATE GOVERNANCE

 

We are committed to high standards of corporate governance, ensuring that our business operations are conducted with integrity, transparency, and accountability. Our corporate governance practices include:

 

• Board of Directors: Our Board of Directors is responsible for setting the strategic direction of the company, overseeing management, and ensuring that we meet our responsibilities to shareholders and other stakeholders. The Board promotes good governance and ethical business practices.

​​

• Governance Documents: We adhere to a comprehensive set of governance documents, including our Corporate Governance Guidelines, Code of Conduct, and Board Committee Charters. These documents outline the principles and practices that guide our governance framework.

​​

• Board Committees: Our Board has established several committees to oversee specific areas of our operations, including the Audit Committee, Compliance, Responsibility and Ethics Committee, Nomination and Governance Committee, and Remuneration Committee. Each committee operates under a formal charter and is composed of independent directors.

​​

• Ethical Business Practices: We are committed to conducting our business with the highest ethical standards. This includes compliance with all relevant laws and regulations, fair labor practices, and environmental stewardship. Our Code of Conduct outlines our commitment to ethical behavior and guides our interactions with stakeholders.

 

COMMITMENT TO TRANSPARENCY & ACCOUNTABILITY

Whole Health Pharmaceuticals, Inc. is committed to building and maintaining trust with our investors through transparency and accountability. We believe that strong corporate governance and clear communication are essential to our success and the confidence of our stakeholders. By providing comprehensive financial reports, detailed annual reports, and robust corporate governance practices, we aim to keep our investors well-informed and engaged. We invite you to explore our Investor Relations section and learn more about our commitment to excellence and sustainable growth